Albumin Infusion for Renal Protection in Liver Cirrhosis

Primary Mechanisms of Renal Protection

• Albumin prevents renal disease in cirrhosis by expanding effective arterial blood volume, thereby counteracting the splanchnic vasodilation and circulatory dysfunction that trigger renal impairment through activation of vasoconstrictor and sodium-retaining systems 1, 2, 3
• For large-volume paracentesis (>5 liters), albumin at 6-8 g per liter of ascites removed reduces PICD by 61% (OR 0.39, 95% CI 0.27-0.55) compared to alternative treatments 1, 4

Prevention of Paracentesis-Induced Circulatory Dysfunction (PICD)

• PICD occurs in 70% of patients undergoing paracentesis without plasma expansion and is diagnosed by plasma renin activity increase >50% above baseline to >4 ng/mL/h on day 6 post-procedure 1, 4
• The International Collaboration for Transfusion Medicine Guidelines notes that albumin is superior to other volume expanders in preventing PICD, though the certainty of evidence for patient-important outcomes remains limited 6

Renal Protection in Spontaneous Bacterial Peritonitis (SBP)

• Albumin combined with antibiotics reduces renal impairment by 54% (OR 0.46, 95% CI 0.30-0.71) and mortality by 34% (OR 0.66, 95% CI 0.45-0.96) at 3 months compared to antibiotics alone 2, 3
• The American Association for the Study of Liver Diseases recommends 1.5 g/kg albumin within 6 hours of SBP diagnosis, followed by 1.0 g/kg on day 3 7, 8

Practical Implementation Algorithm

• For large-volume paracentesis (>5 liters), administer 8 g albumin per liter of ascites removed using 20% or 25% albumin solution 7
• For Spontaneous Bacterial Peritonitis, give 1.5 g/kg albumin within 6 hours of diagnosis, followed by 1.0 g/kg on day 3 7, 8
• Prioritize albumin use for patients with elevated creatinine or bilirubin (creatinine >1 mg/dL or bilirubin >4 mg/dL) 6, 7

Important Caveats and Pitfalls

• The evidence supporting albumin for renal protection has significant limitations, including small patient numbers, imprecise outcomes, and surrogate endpoint concerns 6
• Albumin should not be used for routine volume replacement in critically ill cirrhotic patients, treatment of hypoalbuminemia alone, or paracentesis removing <5 liters 7, 8, 5, 1